Our discovery of mutations in the CIDEB gene that protect against liver disease is published in @NEJM, leading to possible #RNAi therapeutics for NASH by Regeneron & Alnylam. 🚨
https://t.co/Y1PSQz9K3i
A short summary of the key findings 🧬🧵↓
We are announcing a PhD Fellowship in dermatology and biostatistics at K.G. Jebsen Center for Genetic Epidemiology @NTNU_ISM! 🎉
You will be exploring serum metabolites from @theHUNTStudy for improved prevention and treatment of psoriasis and eczema.
Our latest research identified mutations in the CIDEB gene that are highly protective against nonalcoholic forms of liver disease. We're using this discovery to bring potentially promising new therapies to the clinic to help people with NASH. #RGCResearch
By studying the genome of ~540K individuals, we discovered that those with a mutated copy of the CIDEB gene have a 53% lower risk for NASH. Discover how we use this research to inform the development of potential therapies. #RGCResearch
The clever people at @NASA have created this deceptively simple yet highly effective data visualisation showing monthly global temperatures between 1880-2021. Watch until the end...
Learn more here - https://t.co/yvLKEgcIZ7
#ClimateEmergency#ClimateCrisis#climate
This paper was a longtime coming. In no particular order, some of the interesting things to learn from the sequencing and analysis of 53,831 human genomes. 1/n
https://t.co/N5xBtfOEbw
PDF: https://t.co/DRUQlztmGt
NEW today in @NatureComms from @cristenw and colleagues: Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
https://t.co/hKoHEEL4o9
CORONAVIRUS. Statens Serum Instituts system til overvågning af influenza omfatter nu også COVID-19. Og vi har brug for din hjælp til at kortlægge, hvordan coronavirussmitten udvikler sig ude i samfundet https://t.co/mqWcv2aYSL #SSI#Coronavirus#Sundhed#Influenza#dkpol#sundpol
Early RCT: no effect of of Lopinavir–Ritonavir vs. standard care in adults hospitalized with severe covid-19 in China (n=199).
~20% in-hospital mortality despite mean age 58y😟
https://t.co/Jdk7ZcHKbr
#stratifiedlockdown for #COVIDdk#COVID19 seems reasonable next step. Current data suggest very low case fatality rate for previously healthy people <50y.
Europe and US in total or partial lockdown to mitigate #COVID19.
Soon more hundreds of millions will be confined to their homes. Huge personal sacrifices. Staggering economic losses.
Ok, we accept the price for the common good. But how does this end? Here are some strategies:
Can I suggest we just use the acronym PGS for Polygenic Score instead of PRS? The word "risk" though it has a basically precise statistical definition has a terrible connotation in general parlance. #ASHG19
Planning your #ASHG19 Friday yet?! I’m as biased as euro PRS applied across ancestries, but highly suggest “Transferability of PRS Across Populations” @ 9 AM in Hall B. I’m co-moderating talks by @popgenepi, @genandgenes, my @umichsph colleague Pedro Orozco del Pino, & @dudutchy!